Trasylol
A 2006 New England Journal of Medicine study has raised serious issues regarding the safety and effectiveness of Trasylol, an injectable drug used to reduce blood loss during heart surgery. Study findings show that patients injected with Trasylol were almost twice as likely as patients not given the drug to die, suffer renal failure, heart attack or stroke. Compared even to the study’s control group (receiving no medication to prevent bleeding), those given Trasylol had an increased risk of death. It is estimated that as many as 10,000 patients now require dialysis treatments as a result of renal failure caused by the use of Trasylol.
Other medications designed to reduce blood loss (such as aminocaprioc acid and tranexamic acid) do not contribute to an increased risk of renal, cardiac, or cerebral events and are proven to be as effective as Trasylol.
As a result of the study’s significant findings, the FDA has issued a public health advisory and a warning to physicians about the dangerous side effects of Trasylol. The FDA is also working with the drug’s manufacturer to examine the safety and benefits of Trasylol in light of this recent data. These efforts don’t relieve the suffering of patients who experienced extreme side effects as a result of Trasylol. If you or someone you love experienced serious side effects because you were administered Trasylol, you deserve fair and equitable compensation and should contact a legal professional to evaluate your case.
The Pennsylvania dangerous drug attorney team at Michael J. O'Connor & Associates is ready to begin tackling your legal problem today. Email or Call our toll free number at 1.800.518.4LAW for a free initial consultation and review of your case.